Incyte Corporation (INCY): Price and Financial Metrics
Incyte Corporation (INCY)
Today's Latest Price: $97.62 USD
Updated Aug 5 6:55pm
Add INCY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
INCY Stock Summary
- Incyte Corp's market capitalization of $21,858,973,546 is ahead of 91.3% of US-listed equities.
- Of note is the ratio of Incyte Corp's sales and general administrative expense to its total operating expenses; merely 9.36% of US stocks have a lower such ratio.
- The ratio of debt to operating expenses for Incyte Corp is higher than it is for about just 6.42% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Incyte Corp are LASR, QTWO, CMBM, BLDP, and SSP.
- INCY's SEC filings can be seen here. And to visit Incyte Corp's official web site, go to www.incyte.com.
INCY Stock Price Chart Technical Analysis Charts
INCY Price/Volume Stats
| Current price | $97.62 | 52-week high | $110.36 |
| Prev. close | $99.95 | 52-week low | $62.48 |
| Day low | $96.25 | Volume | 1,390,000 |
| Day high | $101.00 | Avg. volume | 1,772,067 |
| 50-day MA | $101.14 | Dividend yield | N/A |
| 200-day MA | $88.72 | Market Cap | 21.22B |
Incyte Corporation (INCY) Company Bio
Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. The company was founded in 1991 and is based in Wilmington, Delaware.
Loading social stream, please wait...